Skip to content

Article

Liability Management Watchlist Monthly – April 2026: Ingenovis and Perforce Launch LMEs as CDK Global Group Dynamics Evolve; 4 New Co-Ops Agreed

Share on X (opens in a new window) Share on Facebook (opens in a new window) Share on LinkedIn (opens in a new window)

Relevant Items:
Liability Management Monthly April 2026
Link to Excel Download
Advisors Database

Octus’ Liability Management Monthly for the month of April is now available. Please email [email protected] for access.

The report highlights developments in liability management exercises, recent cooperation agreements signed and the capital structures of most interest to our subscribers during the month of April. It also details the advisors hired to work with performing companies and their creditors in April, as sourced from Octus’ proprietary Advisors Database.

Featured topics include the launch of LMEs at Ingenovis Health and Perforce Software, the evolution of lender group dynamics at CDK Global and developments in the litigation stemming from transactions at Wesco Aircraft, Optimum Communications Inc. and Starz Entertainment Corp., and STG Logistics Inc.’s announcement of a “global settlement.”

Octus reported on four new cooperation agreements during the month involving creditors of Solera Holdings Inc., Mercer International Inc., Advancing Eyecare and CDK Global Inc.

During April, according to sources, advisors were hired by companies and creditor groups for 45 distinct situations, including Medallia Inc., Lumen Technologies, Advancion, Brightline Florida, Innovative Chemical Products Group and Interior Logic Group, among others. Octus’ proprietary Advisors Database also includes advisors hired for bankrupt credits, although these are excluded from the list below, save for those advisors hired prior to the bankruptcy.

A list of the most-viewed capital structures by Octus subscribers during April as well as links to recent LME work for each of the credits is available upon request.

This publication has been prepared by Octus Intelligence, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2026 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.